Nausea and Digestive Upset Nausea and other digestive issues are among the most common side effects when starting GLP-1 medications, affecting up to 70% of patients, especially during the initial phase of treatment
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Hence, GLP-1 may be key to improving cognitive decline in patients with depression
Final concentration determines injection volume: a 200mg vial mixed with 2mL water yields 100mg/mL, requiring a 1mL injection for a 100mg dose
Discuss significantly elevated liver enzymes, persistent symptoms, or other abnormal results with a qualified healthcare professional, and do not start, stop, or change any medication based on a test result alone
Demand has been explosive, with Novo Nordisk and Eli Lilly struggling to meet it